Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Yau

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 12, 2025
How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?Kevin Yau, Heather N Reich
Kidney360|February 9, 2026
The Oxford Classification Should Remain the Gold Standard for Classification of IgA Nephropathy: PROKevin Yau, Rohan John, Heather N Reich
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 13, 2022
Drug eruption associated with empagliflozinKevin Yau, Stephanie Poon, Bourne L Auguste
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 18, 2023
Kevin Yau, Stephanie Poon, Bourne L Auguste
Diabetes, Obesity & Metabolism|August 27, 2025
Biomarkers for cardiovascular-kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatmentKevin Yau, David Z I Cherney, Ayodele Odutayo
Current Opinion in Nephrology and Hypertension|March 6, 2025
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyondLabib Faruque, Kevin Yau, David Z I Cherney
Journal of Nephrology|July 3, 2021
Spontaneous perirenal hemorrhage leading to Page kidney in a kidney allograft: a case of recurrent Wunderlich syndromeKevin Yau, Sonia Rodriguez-Ramirez, Sang Joseph Kim
Kidney International Reports|July 11, 2022
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical ConsiderationsKevin Yau, Atit Dharia, Ibrahim Alrowiyti, et al.
Kidney International Reports|December 19, 2022
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical ConsiderationsKevin Yau, Atit Dharia, Ibrahim Alrowiyti, et al.
The Canadian Journal of Cardiology|July 10, 2023
Biology and Clinical Use of Glucagon-Like Peptide-1 Receptor Agonists in Vascular ProtectionKevin Yau, Ayodele Odutayo, Satya Dash, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 12, 2025
How should we measure and interpret glomerular inflammation and what is the best anti-inflammatory approach in IgA nephropathy?Kevin Yau, Heather N Reich
Kidney360|February 9, 2026
The Oxford Classification Should Remain the Gold Standard for Classification of IgA Nephropathy: PROKevin Yau, Rohan John, Heather N Reich
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 13, 2022
Drug eruption associated with empagliflozinKevin Yau, Stephanie Poon, Bourne L Auguste
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 18, 2023
Kevin Yau, Stephanie Poon, Bourne L Auguste
Diabetes, Obesity & Metabolism|August 27, 2025
Biomarkers for cardiovascular-kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatmentKevin Yau, David Z I Cherney, Ayodele Odutayo
Current Opinion in Nephrology and Hypertension|March 6, 2025
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyondLabib Faruque, Kevin Yau, David Z I Cherney
Journal of Nephrology|July 3, 2021
Spontaneous perirenal hemorrhage leading to Page kidney in a kidney allograft: a case of recurrent Wunderlich syndromeKevin Yau, Sonia Rodriguez-Ramirez, Sang Joseph Kim
Kidney International Reports|July 11, 2022
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical ConsiderationsKevin Yau, Atit Dharia, Ibrahim Alrowiyti, et al.
Kidney International Reports|December 19, 2022
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical ConsiderationsKevin Yau, Atit Dharia, Ibrahim Alrowiyti, et al.
The Canadian Journal of Cardiology|July 10, 2023
Biology and Clinical Use of Glucagon-Like Peptide-1 Receptor Agonists in Vascular ProtectionKevin Yau, Ayodele Odutayo, Satya Dash, et al.
Pageof 5